Enhancing the Outcome of Skills Training for People With Schizophrenia

Skills Training for Schizophrenia: Enhancing Outcomes

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00069433

Enrollment

Registered

2003-10-09

Start date

2001-04-30

Completion date

2005-11-30

Last updated

2013-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Keywords

Psychotic Disorders

Brief summary

This study will determine the effectiveness of skills training in people with schizophrenia and the applicability of the acquired skills in the real world.

Detailed description

People with schizophrenia have a large number of social and symptom management training programs available to them. Studies suggest that these training programs are effective, but their generalizability and effectiveness in outpatient settings has not been thoroughly examined. This study will examine the treatment outcomes of a skills training approach in schizophrenic individuals taking antipsychotic medication. Participants taking stable doses of risperidone, olanzapine, or quetiapine will be randomly assigned to receive either intensive symptom management and social skills training or group therapy for 12 months. A verbal memory test will be used to stratify the randomization procedure and to control for neurocognitive functioning.

Interventions

PROCEDURESocial skills and symptom management training

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Inclusion criteria

* Diagnosis of schizophrenia or schizoaffective disorder for \> 5 years * Use of stable dose risperidone, olanzapine, or quetiapine for at least 1 month with no planned medication changes * Social Behavior Scale (SBS) score \> 45 * Willing and able to provide informed consent

Exclusion criteria

* Intelligence Quotient \< 70 * Use of more than one antipsychotic medication * Use of benzodiazepines, tricyclic antidepressants, or anticholinergic medication commonly used to treat extrapyramidal symptoms * Diagnostic and Statistical Manual (DSM)-IV criteria for alcohol or other substance dependence * History of any traumatic brain injury leading to loss of consciousness for \> 30 minutes * Diagnosis of a comorbid medical condition that could interfere with antipsychotic medication treatment or the ability to complete the study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026